Finoriq research workspace
Biofrontera Inc. (BFRI) Company Overview
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical. Review BFRI filings, fundamentals, valuation, and ownership on Finoriq.
Company Snapshot
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
- Company
- Biofrontera Inc. (BFRI)
- Ticker
- BFRI
- Market Cap
- $13.6M
- Latest Price
- $1.065
- Industry
- Biotech & Pharma
Biofrontera Inc. (BFRI) Current Valuation Metrics
Static valuation preview for Biofrontera Inc. (BFRI). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 0.35x | Revenue | TTM FY 2025 |
| Earnings YieldLatest TTM net income divided by market cap. | -72.2% | Net Income | TTM FY 2025 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -91.5% | Operating Cash Flow | TTM FY 2025 |
| Price / BookMarket cap divided by stockholders' equity. | 1.39x | Stockholders' Equity | FY 2025 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.